David Lipanovic

Senior Clinical Reporter

NICE terminates appraisal of medicine for the treatment of persistent cough

Manufacturer Merck Sharpe & Dohme has decided not to supply the National Institute for Health and Care Excellence with evidence on use of gefapixant (Lyfnua).…

ADHD hub planned for launch in autumn 2024

The hub will support shared-care arrangement for adults with attention deficit hyperactivity disorder in Leeds, West Yorkshire.…

ADHD drugs back in stock, says manufacturer

Exclusive: Medicines used to treat ADHD manufactured by Takeda are now available, following a period of supply issues caused by an increase in demand and production challenges.…

NHS England to fund additional 3,000 independent prescriber places for 2024/2025

There will be funding for independent prescribing places for community pharmacy, hospital and general practice, according to a presentation by the chief pharmaceutical officer for England at the Clinical Pharmacy Congress.…

Pharmacists and pharmacy technicians to be able to supply naloxone without a prescription

The expanded access to take-home naloxone follows two government consultations carried out in 2021 and 2024, respectively.…

First 14 independent prescribing pathfinder sites have gone live, says NHS England

Wasim Baqir, senior pharmacist at NHS England's pharmacy integration fund, said funding had been confirmed for the Independent Prescribing Pathfinder Programme to be delivered this year.…

Government backs two new models of hub-and-spoke dispensing

The Department of Health and Social Care has said it will implement both models between pharmacies that are not within the same legal entity.…

Half of all trusts could be using electronic prescription service by 2026, says NHS England

NHS England’s clinical lead for digital medicines said it would be working with at least eight system suppliers to provide the service.…

Varenicline planned for return but ‘not before’ end of 2024, says manufacturer

Pfizer has said smoking cessation therapy varenicline will be reintroduced to the UK, after being withdrawn in October 2021.…

Regulator approves first injectable treatment for prevention of HIV

Cabotegravir has been approved as pre-exposure prophylaxis in the UK in both tablet and injectable form.…